OR WAIT null SECS
February 14, 2020
The company has said that all three of its operating sites in China started back up on Feb. 12 and that it is closely monitoring the outbreak.
February 12, 2020
The report details OPQ’s accomplishments over the past five years.
February 02, 2020
Increased reliance on foreign producers raises concerns and spurs collaborations.
Data management is crucial in bio/pharmaceutical laboratory settings from discovery steps through clinical studies and varies based on the development phase.
Complex protein structures pose analytical challenges that can be addressed by advanced mass spectrometry technologies and workflows, which can be used to comprehensively characterize them.
January 31, 2020
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
January 17, 2020
FDA sent a warning letter to Health Pharma USA after an inspection found the company’s quality unit was not properly overseeing its drug manufacturing operations.
January 09, 2020
The company has various projects and launches scheduled for 2020 as part of its anniversary celebration.
January 03, 2020
The agency sent a warning letter to Henan Kangdi Medical Devices Co. Ltd after an inspection found CGMP violations that included a variety of failures of the company’s quality unit.
January 02, 2020
FDA sent a warning letter to GPT Pharmaceuticals Pvt. Ltd. after inspectors found CGMP violations that included equipment that was not properly maintained.